All data are based on the daily closing price as of February 27, 2026
s
Sunmax Biotechnology
4728.TWO
12.45 USD
-0.04
-0.32%
Overview
Last close
12.45 usd
Market cap
678.10M usd
52 week high
16.58 usd
52 week low
7.93 usd
Target price
N/A usd
Valuation
P/E
29.5887
Forward P/E
N/A
Price/Sales
10.5949
Price/Book Value
14.6486
Enterprise Value
654.77M usd
EV/Revenue
18.2114
EV/EBITDA
21.4739
Key financials
Revenue TTM
63.64M usd
Gross Profit TTM
50.33M usd
EBITDA TTM
33.65M usd
Earnings per Share
0.42 usd
Dividend
0.37 usd
Total assets
62.30M usd
Net debt
N/A usd
About
Sunmax Biotechnology Co., Ltd., a biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China. The company offers dermal fillers, including Sunmax Deusaderm VITAL and Sunmax Deusaderm LIDO Injectable Collagen Gel with Lidocaine. The company was founded in 2001 and is headquartered in Tainan City, Taiwan.